Completed PHASE4 INTERVENTIONAL 2-arm NCT00498472

NT-proBNP in the Optimization of Treatment After Recent Acute Heart Failure Trial (BOT_AcuteHF)

NT-proBNP in the Optimization of Treatment After Recent Acute Heart Failure (BOT-AcuteHF) Trial

Sponsor: Università degli Studi di Brescia

Interventions Pre-discharge NT-ProBNP based treatment

Updated 5 times since 2017 Last updated: Jun 14, 2010 Started: Jul 31, 2006 Primary completion: Apr 30, 2010 Completion: Apr 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Acute Heart Failure, this trial is completed. The trial is conducted by Università degli Studi di Brescia and has accumulated 5 data snapshots since 2006. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jul 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Università degli Studi di Brescia

Data source: Università degli Studi di Brescia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brescia, Italy